Avidity Biosciences
RNA
NASDAQ
IPO2020
about RNA
Avidity Biosciences discovers, develops, and delivers innovative therapeutic proteins and RNA-based solutions aimed at addressing diseases with significant unmet needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $14.58 | $15.93 | $13.06 | $11.3B | 5.07M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.27 | n/a | 154.75 | -1513.47% | -1398.33% | 0% |